Search
Regulatory Story
Company Kainos Group plc
TIDM KNOS
Headline Director/PDMR Shareholding
Released 11:31 07-Mar-2019
Number 1963S11

RNS Number : 1963S
Kainos Group plc
07 March 2019
 

07 March 2019

Kainos Group plc

 

("Kainos" or the "Company") 

Director/PDMR Shareholdings

The Company has been notified that on 06 March 2019, Dr John Lillywhite, Chairman, transferred 40,000 ordinary shares in the Company, to a Charitable Incorporated Organisation (CIO), for nil consideration.

 

The Lillywhite Family Trust (Charity number: 1181785) has been established to promote and advance exclusively charitable purposes, namely the provision of funding for bursaries and scholarships for disadvantaged young people.

 

Following this notification, Dr Lillywhite holds 460,000 ordinary shares in the Company, representing approximately 0.38% of the total issued shares in the Company.

 

This announcement is made in accordance with the requirements of the EU Market Abuse Regulation.

 

The notification of dealing form is set out below:

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 

1.         

Details of the person discharging managerial responsibilities / person closely associated

a.         

Name

Dr John Lillywhite

2.         

Reason for the notification

a.         

Position/status

Chairman/Director

b.         

Initial notification

/Amendment

Initial

3.         

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.         

Name

Kainos Group plc

b.         

LEI

213800H2PQMIF3OVZY47

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

 

 

ISIN: GB00BZ0D6727

b.         

Nature of the transaction

Transfer of Ordinary Shares of £0.005 each to the Lillywhite Family Trust for nil consideration. The Lillywhite Family Trust is a Charitable Incorporated Organisation (CIO), Charity Number: 1181785.

c.         

Price(s) and volume(s)

Price(s)

Volume(s)

NIL

40,000

 

d.         

Aggregated information

·      Aggregated volume

·      Price

 

N/A

e.         

Date of the transaction

06-03-2019

f.         

Place of the transaction

Outside of a trading venue

 

 

Ends

 

For further information, please contact:

 

Kainos                                                                                           via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc                                                                               +44 20 7597 5970

Patrick Robb / Sebastian Lawrence

 

Canaccord Genuity                                                                             +44 20 7523 4606

Simon Bridges / Emma Gabriel

 

FTI Consulting LLP                                                                             +44 20 3727 1000

Matt Dixon / Harry Staight

 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

 

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

 

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers.

 

Kainos has over 1,300 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

 

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com
 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHCKODBDBKDFNK
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.